Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Blerta Beluli"'
Autor:
Elias Ewais, Justus Strauch, Polykarpos C. Patsalis, Matthias Bechtel, Dritan Useini, Peter L. Haldenwang, Markus Schlömicher, Blerta Beluli, V. Moustafine, Hildegard Christ
Publikováno v:
Journal of Cardiac Surgery. 36:610-617
OBJECTIVES Little data have been published on the midterm effect of transapical/transfemoral-transcatheter aortic valve replacement (TA-/TF-TAVR) using the Edwards SAPIEN 3 valve (S3). We aimed to compare the outcomes after TA-/TF-TAVR utilizing the
Autor:
Markus Schlömicher, Matthias Bechtel, Peter L. Haldenwang, Blerta Beluli, Dritan Useini, Justus Strauch
Publikováno v:
The Annals of Thoracic Surgery. 110:e189-e192
The Edwards INTUITY aortic valve has in recent years played a significant role in facilitating surgical aortic valve replacement. Owing to the excellent hemodynamic characteristics and relatively new usage of this bioprosthetic aortic valve, the stru
Autor:
Justus Strauch, Peter L. Haldenwang, Dritan Useini, Andreas Mügge, Blerta Beluli, Markus Schlömicher, Matthias Bechtel, Hildegard Christ, Polykarpos C. Patsalis
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 69:445-454
Background A certain degree of prosthesis oversizing is recommended for the SAPIEN 3 (S3; Edwards Lifesciences Corp., Irvine, California, United States) to ensure device success. We aimed to investigate midterm outcomes in patients who received overs
Autor:
Dritan USEINI, Markus SCHLÖMICHER, Blerta BELULI, Hildegard CHRIST, Elias EWAIS, Peter HALDENWANG, Polykarpos PATSALIS, Vadim MOUSTAFINE, Matthias BECHTEL, Justus STRAUCH
Publikováno v:
The Journal of cardiovascular surgery. 62(6)
Scarcely any data has been published on the mid-term effect of transapical-transcatheter aortic valve implantation (TA-TAVI) using the Edwards SAPIEN 3 valve (S3; Edwards Lifesciences Corp., Irvine, CA, USA). We present mid-term clinical and echocard
Autor:
Polykarpos C. Patsalis, Blerta Beluli, Dritan Useini, Markus Schlömicher, Hildegard Christ, Peter L. Haldenwang, Justus Strauch
Publikováno v:
The Thoracic and cardiovascular surgeon. 70(3)
Introduction Though transfemoral (TF) access has emerged as a gold standard access for patients with aortic stenosis who undergo transcatheter aortic valve implantation (TAVI), there has been no study that has characterized patients who cannot underg
Publikováno v:
Journal of cardiac surgeryREFERENCES. 36(7)
OBJECTIVES Some patients who undergo transcatheter aortic valve replacement (TAVR) have a concomitant diverse aortic pathologies (AP). They are usually considered high-risk candidates for the procedure and require further assessment to determine the
Autor:
Blerta Beluli, Peter L. Haldenwang, Markus Schlömicher, Justus Strauch, Hamid Naraghi, Hildegard Christ, Elias Ewais, Dritan Useini, V. Moustafine, Polykarpos C. Patsalis, Matthias Bechtel
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 59(6)
OBJECTIVES Patients scheduled for transcatheter aortic valve implantation (TAVI) treatment frequently present with concomitant aortic diseases, in which case they are usually considered to be at high interventional risk and, in particular, unable to
Autor:
Useini, Dritan1 (AUTHOR) dritan-83@live.com, Beluli, Blerta2 (AUTHOR), Christ, Hildegard3 (AUTHOR), Strauch, Justus1 (AUTHOR)
Publikováno v:
Journal of Cardiac Surgery. Jul2021, Vol. 36 Issue 7, p2240-2246. 7p. 1 Color Photograph, 4 Charts, 2 Graphs.
Autor:
Useini, Dritan1 (AUTHOR) dritan-83@live.com, Beluli, Blerta2 (AUTHOR), Christ, Hildegard3 (AUTHOR), Schlömicher, Markus1 (AUTHOR), Ewais, Elias1 (AUTHOR), Haldenwang, Peter1 (AUTHOR), Patsalis, Polykarpos4 (AUTHOR), Moustafine, Vadim1 (AUTHOR), Bechtel, Matthias1 (AUTHOR), Strauch, Justus1 (AUTHOR)
Publikováno v:
Journal of Cardiac Surgery. Feb2021, Vol. 36 Issue 2, p610-617. 8p. 4 Charts, 2 Graphs.